InMed Pharmaceuticals (INM) Enterprise Value (2021 - 2025)
Historic Enterprise Value for InMed Pharmaceuticals (INM) over the last 5 years, with Q3 2025 value amounting to -$9.4 million.
- InMed Pharmaceuticals' Enterprise Value fell 6783.6% to -$9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.4 million, marking a year-over-year decrease of 6783.6%. This contributed to the annual value of -$11.1 million for FY2025, which is 6809.98% down from last year.
- Per InMed Pharmaceuticals' latest filing, its Enterprise Value stood at -$9.4 million for Q3 2025, which was down 6783.6% from -$11.1 million recorded in Q2 2025.
- InMed Pharmaceuticals' 5-year Enterprise Value high stood at -$3.5 million for Q4 2024, and its period low was -$15.4 million during Q3 2021.
- For the 5-year period, InMed Pharmaceuticals' Enterprise Value averaged around -$8.4 million, with its median value being -$9.0 million (2023).
- Its Enterprise Value has fluctuated over the past 5 years, first soared by 6303.74% in 2024, then tumbled by 6809.98% in 2025.
- Over the past 5 years, InMed Pharmaceuticals' Enterprise Value (Quarter) stood at -$11.3 million in 2021, then dropped by 1.5% to -$11.5 million in 2022, then increased by 16.67% to -$9.6 million in 2023, then skyrocketed by 63.04% to -$3.5 million in 2024, then tumbled by 166.69% to -$9.4 million in 2025.
- Its last three reported values are -$9.4 million in Q3 2025, -$11.1 million for Q2 2025, and -$4.7 million during Q1 2025.